ClinConnect ClinConnect Logo
Search / Trial NCT05345340

Telemedicine in Functional Motor Disorder

Launched by UNIVERSITA DI VERONA · Apr 19, 2022

Trial Information

Current as of May 08, 2025

Unknown status

Keywords

Telemedicine Gait Economic Costs Pain Fatigue

ClinConnect Summary

Functional movement disorders (FMDs) are part of a broad spectrum of functional neurological disorders characterized by abnormal movements (gait, dystonia, and tremor), which are clinically incongruent with movement disorders caused by neurological disease and are significantly altered distraction or nonphysiologically maneuvers. FMDs have an incidence ranging from 4 to 12 per 100.000 population per year and a high prevalence (15-20%) in patients accessing neurological clinics. They are high disabling conditions characterized by long-term disability, poor quality of life, and economic impac...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • a clinically definite diagnosis of FMDs based on Gupta and Lang diagnostic criteria with the presence of distractibility maneuvers and a demonstration of positive signs;
  • the presence of 1 (isolated FMDs) or more clinical motor symptoms (combined FMDs), including weakness, tremor, jerks, dystonia, gait disorders, and parkinsonism;
  • acceptable level of digital skills.
  • Exclusion Criteria:
  • prominent dissociative seizures
  • prominent cognitive and physical impairment that precludes signing the informed consent for participation in the study;
  • unable or refuse to attend the consecutive 5-day rehabilitation treatment

About Universita Di Verona

The Università di Verona is a prestigious academic institution in Italy, renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university collaborates with various healthcare professionals and institutions to explore new therapies and improve patient outcomes. Its research initiatives are driven by a multidisciplinary approach, leveraging cutting-edge technology and methodologies. The Università di Verona aims to contribute significantly to the scientific community and public health by fostering rigorous clinical studies that address pressing medical challenges.

Locations

Verona, , Italy

Patients applied

0 patients applied

Trial Officials

Federico Schena, PhD

Study Director

Universita di Verona

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials